Search Results for: PRKAR2A

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
AKAP8 A-kinase anchoring protein 8
AKAP9 A-kinase anchoring protein 9
  • Regulation of PLK1 Activity at G2/M Transition
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Phase 3 - rapid repolarisation
  • Phase 2 - plateau phase
  • Anchoring of the basal body to the plasma membrane
  • Signaling by BRAF and RAF fusions
  • AURKA Activation by TPX2
  • Long QT syndrome, including: Romano-Ward syndrome; Jervell and Lange-Nielsen syndrome (JLNS)
ARFGEF2 ADP ribosylation factor guanine nucleotide exchange factor 2
  • Association of TriC/CCT with target proteins during biosynthesis
  • Periventricular nodular heterotopia (PVNH)
CBFA2T3 CBFA2/RUNX1 partner transcriptional co-repressor 3
CFTR CF transmembrane conductance regulator
  • ABC-family proteins mediated transport
  • RHO GTPases regulate CFTR trafficking
  • Defective CFTR causes cystic fibrosis
  • Ub-specific processing proteases
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • Chaperone Mediated Autophagy
  • Late endosomal microautophagy
  • Aggrephagy
  • Aggrephagy
  • ATP
  • Bumetanide
  • Glyburide
  • Ibuprofen
  • Colforsin
  • Phosphoaminophosphonic Acid-Adenylate Ester
  • Dexfosfoserine
  • Crofelemer
  • Lonidamine
  • Ivacaftor
  • Dexibuprofen
  • Lumacaftor
  • Tezacaftor
  • Elexacaftor
  • Cystic fibrosis (CF)
  • Hereditary pancreatitis; Hereditary chronic pancreatitis
  • Congenital bilateral absence of vas deferens
EZR ezrin
  • Netrin-1 signaling
  • Recycling pathway of L1
  • Recycling pathway of L1
FOS Fos proto-oncogene, AP-1 transcription factor subunit
  • Oxidative Stress Induced Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • FCERI mediated MAPK activation
  • Activation of the AP-1 family of transcription factors
  • Interleukin-4 and Interleukin-13 signaling
  • TP53 Regulates Transcription of DNA Repair Genes
  • Estrogen-dependent gene expression
  • NGF-stimulated transcription
  • NGF-stimulated transcription
  • Estrogen-dependent nuclear events downstream of ESR-membrane signaling
  • Pseudoephedrine
  • Nadroparin
LRIF1 ligand dependent nuclear receptor interacting factor 1
MAP2 microtubule associated protein 2
  • Estramustine
  • Paclitaxel
  • Docetaxel
MYCBPAP MYCBP associated protein
NBEA neurobeachin
  • Neurotransmitter receptors and postsynaptic signal transmission
  • PKA activation
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Assembly and cell surface presentation of NMDA receptors
PJA2 praja ring finger ubiquitin ligase 2
  • Antigen processing: Ubiquitination & Proteasome degradation
PPP1CB protein phosphatase 1 catalytic subunit beta
  • Triglyceride catabolism
  • Downregulation of TGF-beta receptor signaling
  • Regulation of PLK1 Activity at G2/M Transition
  • Circadian Clock
  • RHO GTPases activate PKNs
  • RHO GTPases activate PKNs
  • RHO GTPases activate CIT
  • RHO GTPases Activate ROCKs
  • RHO GTPases activate PAKs
  • RHO GTPases activate PAKs
  • RAF activation
  • Signaling by MRAS-complex mutants
PRKX protein kinase X-linked
  • PKA-mediated phosphorylation of CREB
  • CREB1 phosphorylation through the activation of Adenylate Cyclase
  • ADORA2B mediated anti-inflammatory cytokines production
  • FCGR3A-mediated IL10 synthesis
RAB32 RAB32, member RAS oncogene family
  • RAB geranylgeranylation
  • RAB GEFs exchange GTP for GDP on RABs
RET ret proto-oncogene
  • RAF/MAP kinase cascade
  • RET signaling
  • Sorafenib
  • 1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine
  • Vandetanib
  • Cabozantinib
  • Regorafenib
  • Ponatinib
  • Lenvatinib
  • Fostamatinib
  • Amuvatinib
  • Selpercatinib
  • Pralsetinib
  • Hirschsprung disease (HD)
  • Renal agenesis and Renal adysplasia
  • Thyroid cancer
  • Congenital central hypoventilation syndrome (CCHS)
RUNX1T1 RUNX1 partner transcriptional co-repressor 1
  • Acute myeloid leukemia (AML)
RYR2 ryanodine receptor 2
  • Stimuli-sensing channels
  • Ion homeostasis
  • Flecainide
  • Tetracaine
  • Arrhythmogenic right ventricular cardiomyopathy (ARVC)
  • Catecholaminergic polymorphic ventricular tachycardia
SCTR secretin receptor
  • G alpha (s) signalling events
  • Glucagon-type ligand receptors
  • ADORA2B mediated anti-inflammatory cytokines production
  • Secretin human
SEMG2 semenogelin 2
  • Zinc chloride
  • Zinc sulfate, unspecified form

Page 2 out of 3 pages